Leadership Team

Ms. Field is currently president of Halo Collective, Inc. (NEO: HALO) (OTCQX: HCANF) ("HALO"), a position she has held since February 2020. From April 2019 through February 2020, Ms. Field served as Chief Strategy Officer at HALO. Ms. Field's resume includes senior positions at The Brookings Institution and Bain & Company. In 2014 she entered the cannabis industry and led the procurement, build out, and sale of one of five original vertically integrated companies with state licenses in Florida. Subsequently, Ms. Field operated a strategy consulting practice focused on cannabis and also worked at MariMed in 2018 as Executive Vice President of Corporate Development. She completed an internship in the public liaison's office of The White House during the George W. Bush administration. Ms. Field holds an MBA from Columbia Business School and a BA with honors from Stanford University.

A Functional and Business Strategy Consultant passionate wellness, healthcare and cannabis. Experienced in designing data driven and innovative Sales, Marketing & Operating Strategies; leading and delivering global transformation programs, facilitating design thinking workshops to collaborate and understand customer journey and operational pain points, designing and implementing new customer experiences, data analytics/ modelling and compliance (GDPR), business case creation and delivering client value.

Mr. Matos became Global Technical Director for Akanda in the 2nd Semester of 2022, following its previous role of Head of Quality and Technical Director for Holigen, a Company previously owned by Flowr Corporation. Having been working much of his 30 plus year professional life in the Pharma Industry, its broad experience in major international companies, from Merck Sharp & Dohme to Novartis as well as his experience in a leading Medicinal gases producer, José brings to Akanda operations a comprehensive understanding of Pharma operations, a key requisite to achieve a high degree of EU GMP compliance, essential to Akanda role as a major player in the Medicinal Cannabis market.